CD200 and neoplasm: However, there is evidence suggesting that CD200 may also contain anti-tumor effects based on its suppression of tumor-promoting inflammation, angiogenesis, expansion of tumor-associated myeloid cells (TAMC), and improvement of the efficacy of anti-PD-1/PD-L1 treatments [8,9,10,11,12,13,14,15,16,17].